Artificial Antigen‐Presenting Cell Fabrication for Murine T Cell Expansion

Abstract

AbstractAntigen‐presenting cells (APCs), such as dendritic cells and macrophages, have a unique ability to survey the body and present information to T cells via peptide‐loaded major histocompatibility complexes (signal 1). This presentation, along with a co‐stimulatory signal (signal 2), leads to activation and subsequent expansion of T cells. This process can be harnessed and utilized for therapeutic applications, but the use of patient‐derived APCs can be complex and inefficient. Alternatively, artificial APCs (aAPCs) provide a simplified method to achieve T cell activation by presenting the two necessary stimulatory signals. This protocol describes the utilization of magnetic nanoparticles and stimulatory proteins to create aAPCs that can be employed for activating and expanding antigen‐specific T cells for both basic and translational immunology and immunotherapy studies. © 2024 Wiley Periodicals LLC.Basic Protocol 1: Protein and particle modification for aAPC fabricationBasic Protocol 2: aAPC validation by immunolabeling of conjugated proteinSupport Protocol 1: Quantification of aAPC stock concentrationBasic Protocol 3: Determination of aAPC usage for murine CD8+ T cell activationSupport Protocol 2: Isolation of murine CD8+ T cells